Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 30;15:3207–3217. doi: 10.2147/JIR.S362774

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Zhu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Clinical values of serum miR-455-5p in CAS and the development of CIEs. (A) Analysis of the clinical diagnostic ability of miR-455-5p in CAS. Serum miR-455-5p showed the diagnostic potential to identify CAS from healthy individuals with the area under the curve (AUC) of 0.927, the diagnostic sensitivity and specificity were 82.9% and 90.8%, respectively. (B) The Kaplan-Meier (K-M) curve that drawn based on the follow-up results. The incidence of CIEs was higher in people carrying low miR-455-5p levels, the Log rank test indicated a significant difference between the low and high miR-455-5p expression group (P = 0.002).